Biomerica (BMRA) Accounts Payables (2011 - 2026)
Biomerica recorded quarterly Accounts Payables of $730000.0 in Q1 2026, down 1.35% quarter-over-quarter from $740000.0 in Q4 2025, and up 15.51% year-over-year from $632000.0 in Q1 2025.
Biomerica's Accounts Payables history runs 16 years deep, the most recent figure standing at $730000.0 for Q1 2026.
- In Q1 2026, Accounts Payables rose 15.51% year-over-year to $730000.0; the TTM figure through Feb 2026 stood at $730000.0 (up 15.51% YoY), while the FY2025 annual figure was $672000.0, up 20.0% from the prior year.
- Accounts Payables came in at $730000.0 for Q1 2026 at Biomerica, down from $740000.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $2.6 million in Q1 2022 to a low of $344000.0 in Q2 2023.
- A 5-year average of $822728.4 and a median of $713000.0 in 2023 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables surged 245.02% in 2022 and sank 85.16% in 2023, its largest moves.
- Biomerica's Accounts Payables stood at $670074.0 in 2022, then rose by 16.85% to $783000.0 in 2023, then advanced by 8.3% to $848000.0 in 2024, then dropped by 12.74% to $740000.0 in 2025, then declined by 1.35% to $730000.0 in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $730000.0, $740000.0, and $681000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.57 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.33 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 338.80 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 | 730,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 730,000.00 |
| Nov 30, 2025 | 740,000.00 |
| Aug 31, 2025 | 681,000.00 |
| May 31, 2025 | 672,000.00 |
| Feb 28, 2025 | 632,000.00 |
| Nov 30, 2024 | 848,000.00 |
| Aug 31, 2024 | 1.09 Mn |
| May 31, 2024 | 560,000.00 |
| Feb 29, 2024 | 885,000.00 |
| Nov 30, 2023 | 783,000.00 |
| Aug 31, 2023 | 713,000.00 |
| May 31, 2023 | 344,000.00 |
| Feb 28, 2023 | 387,228.00 |
| Nov 30, 2022 | 670,074.00 |
| Aug 31, 2022 | 671,240.00 |
| May 31, 2022 | 972,000.00 |
| Feb 28, 2022 | 2.61 Mn |
| Nov 30, 2021 | 1.58 Mn |
| Aug 31, 2021 | 641,404.00 |
| May 31, 2021 | 583,380.00 |
| Feb 28, 2021 | 756,136.00 |
| Nov 30, 2020 | 1.26 Mn |
| Aug 31, 2020 | 1.27 Mn |
| May 31, 2020 | 986,711.00 |
| Feb 29, 2020 | 1.27 Mn |
| Nov 30, 2019 | 1.34 Mn |
| Aug 31, 2019 | 943,875.00 |
| May 31, 2019 | 1.04 Mn |
| Feb 28, 2019 | 852,985.00 |
| Nov 30, 2018 | 800,470.00 |
| Aug 31, 2018 | 548,283.00 |
| May 31, 2018 | 655,599.00 |
| Aug 31, 2017 | 440,043.00 |
| May 31, 2017 | 336,430.00 |
| Feb 28, 2017 | 482,663.00 |
| Nov 30, 2016 | 367,158.00 |
| Aug 31, 2016 | 263,177.00 |
| May 31, 2016 | 333,485.00 |
| Feb 29, 2016 | 327,007.00 |
| Nov 30, 2015 | 315,834.00 |
| Aug 31, 2015 | 405,326.00 |
| May 31, 2015 | 392,139.00 |
| Feb 28, 2015 | 352,945.00 |
| Nov 30, 2014 | 249,978.00 |
| Aug 31, 2014 | 230,444.00 |
| May 31, 2014 | 441,681.00 |
| Feb 28, 2014 | 317,464.00 |
| Nov 30, 2013 | 279,974.00 |
| Aug 31, 2013 | 324,652.00 |
| May 31, 2013 | 282,138.00 |
| Feb 28, 2013 | 366,389.00 |
| Nov 30, 2012 | 333,222.00 |
| Aug 31, 2012 | 338,423.00 |
| May 31, 2012 | 362,447.00 |
| Feb 29, 2012 | 451,828.00 |
| Nov 30, 2011 | 266,096.00 |
| Aug 31, 2011 | 388,020.00 |
| May 31, 2011 | 451,569.00 |